Autoinuminous necrotizing myositis: Case report and literature review
DOI:
https://doi.org/10.35434/rcmhnaaa.2023.161.1484Keywords:
Myopathy, autoimmune, necrotizingAbstract
Introduction: autoimmune necrotizing myositis is a rare disease in our environment, but it constitutes one of the forms of autoimmune inflammatory myopathies in approximately 20% of cases. Case report: This paper presents the case of a patient who was hospitalized in the internal medicine service who had a favorable outcome after his diagnosis. Conclusion: Autoimmune necrotizing myositis is an inflammatory myopathy that is difficult to diagnose, but is increasingly prevalent among myopathies.
Downloads
Metrics
References
Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Curr Rheumatol Rep. 2018;20(4):21. doi: 10.1007/s11926-018-0732-6
Bevilacqua J, Earle N. Miopatías inflamatorias. revista medica clinica las condes. 2018;29(6):611-21. doi: 10.1016/j.rmclc.2018.09.002
Bertorini T, Meza K, Chunga N. Miopatías autoinmunes: revisión de diagnóstico y manejo. An Fac med. 2019;80(3):362-71. doi: 10.15381/anales.803.16274
Oldroyd A, Lilleker J, Chinoy H. Idiopathic inflammatory myopathies – a guide to subtypes, diagnostic approach and treatment. Clin Med (Lond). 2017;17(4):322-8. doi: 10.7861/clinmedicine.17-4-322
Cachay-Díaz JR, Carrasco-De la Cruz S, Maya-Pérez A, Valencia-Caballero V, Huamán-Muñante J, Arangüena-Necochea L, Becerra V. Miopatía autoinmune necrotizante. spmi [Internet]. 2019 [Citado 2 de agosto de 2022];27(3):140-3. Disponible en: https://revistamedicinainterna.net/index.php/spmi/article/view/1
Mammen A. Autoimmune muscle disease. Handb Clin Neurol. 2016;133:467–84. doi: 10.1016/B9780-444-63432-0.00025-
Werner JL, Christopher-Stine L, Ghazarian SR, et al. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum. 2012;64: 4087e93. doi: 10.1002/art.34673
Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve. 2015;51(5):638-56. doi: 10.1002/mus.24566
Lundberg IE, Tjarnlund A, Bottai M, et al. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol Hoboken NJ. 2017;69:2271e82. doi: 10.1136/rmdopen-2017-000507
Oddis CV, Reed AM, Aggarwal R, et al. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum. 2013;65:314e24. doi: 10.1002/art.37754
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Victor Andres Cabrera Taipe, Luis Coaguila La Torre , Angela Paredes Mayorca
This work is licensed under a Creative Commons Attribution 4.0 International License.
